<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36394933</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0042-8833</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>5</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Voprosy pitaniia</Title><ISOAbbreviation>Vopr Pitan</ISOAbbreviation></Journal><ArticleTitle>[Efficacy of newly developed kombucha-based specialized food product for treatment of constipation-predominant irritable bowel syndrome].</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>104</EndPage><MedlinePgn>95-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33029/0042-8833-2022-91-5-95-104</ELocationID><Abstract><AbstractText>According to studies, the prevalence of constipation in the population can reach 27% due to the low intake of dietary fiber. Increasing dietary fiber intake can improve bowel movements. <b>The aim</b> of the study was to assess the efficacy of a non-alcoholic fermented pasteurized kombucha drink enriched with inulin and vitamins in patients with constipation-predominant irritable bowel syndrome (IBS). <b>Material and methods</b>. The study (NCT05164861) was approved by Local Ethics Committee and enrolled subjects with IBS (according to ROME IV). The subjects were randomized to receive either 220 ml of a non-alcoholic drink, based on pasteurized kombucha (KG), enriched with inulin (1.15 g/100 ml) or 220 ml water (control group, CG), for 10 days. Standard examination included evaluation of stool frequency (bowel movements per day), stool form (with the Bristol stool scale) and evaluation of concomitant symptoms (abdominal pain/discomfort, abdominal fullness, bloating, and feeling of incomplete bowel emptying) with the use of 5-point Likert scale before (BL) and 10 days after the start of intervention (EOT). Using visual analog scales (VAS), the palatability of the studied food was assessed at the beginning and end of the observation period. <b>Results</b>. Significant increase of stool frequency was found at the EOT compared to BL in KG (n=20), Mean&#xb1;SD: 0.60&#xb1;0.31 to 0.85&#xb1;0.19 times/day; p=0.004, while there was no change in CG (n=20): 0.63&#xb1;0.33 vs 0.72&#xb1;0.28, p=0.6. Mean values of stool scale form increased in KG (3.0&#xb1;1.2 to 4.4&#xb1;1.0, p=0.001), while remained unchanged in CG (2.9&#xb1;1.2 vs 3.4&#xb1;1.2, p=0.6). Mean values of the Bristol stool scale in KG and CG differed significantly at EOT (p=0.018). Significant decrease in mean values of incomplete bowel emptying feeling was found in KG (1.88&#xb1;0.78 at BL vs 1.41&#xb1;0.56 points at EOT, p=0.015), but not in the control group. There were no statistically significant differences between patient's reports of the studied groups for other symptoms (bitterness and dryness in the mouth, heartburn, nausea, abdominal pain and heaviness in the stomach after eating). <b>Conclusion</b>. The effectiveness of a pasteurized fermented non-alcoholic drink based on kombucha enriched with inulin has been proven by reducing the intensity of complaints significant for constipation, normalizing the frequency and consistency of stools.</AbstractText><CopyrightInformation>Copyright&#xa9; GEOTAR-Media Publishing Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pilipenko</LastName><ForeName>V I</ForeName><Initials>VI</Initials><Identifier Source="ORCID">0000-0001-5632-1880</Identifier><AffiliationInfo><Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isakov</LastName><ForeName>V A</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0002-4417-8076</Identifier><AffiliationInfo><Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozov</LastName><ForeName>S V</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0001-6816-3058</Identifier><AffiliationInfo><Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlasova</LastName><ForeName>A V</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-2966-1171</Identifier><AffiliationInfo><Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kochetkova</LastName><ForeName>A A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-9821-192X</Identifier><AffiliationInfo><Affiliation>Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author></AuthorList><Language>rus</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05164861</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Russia (Federation)</Country><MedlineTA>Vopr Pitan</MedlineTA><NlmUniqueID>2984870R</NlmUniqueID><ISSNLinking>0042-8833</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9005-80-5</RegistryNumber><NameOfSubstance UI="D007444">Inulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004043">Dietary Fiber</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007444" MajorTopicYN="N">Inulin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="N">Constipation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015746" MajorTopicYN="N">Abdominal Pain</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019648" MajorTopicYN="Y">Foods, Specialized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004043" MajorTopicYN="N">Dietary Fiber</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">functional food</Keyword><Keyword MajorTopicYN="N">inulin</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome with constipation</Keyword><Keyword MajorTopicYN="N">kombucha</Keyword></KeywordList><CoiStatement>The authors declare no overt and potential conflict of interest related to the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>14</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36394933</ArticleId><ArticleId IdType="doi">10.33029/0042-8833-2022-91-5-95-104</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>